 
 
Parental perceptions on prescription opi[INVESTIGATOR_685984]  
 
 
[STUDY_ID_REMOVED] 
  
May 12, 2022  
NATIONWIDE CHILDREN’S HOSPI[INVESTIGATOR_685985]  (Waiver of C onsent or Verbal Consent) 
 
PROTOCOL TITLE:  Parental perceptions on prescription opi[INVESTIGATOR_685986] 1 of 7
 HRP -580  v.04.17.19  PROTOCOL TITLE:  
Parental perceptions on prescription opi[INVESTIGATOR_685987]:  
Joseph D. Tobias, MD Department of Anesthesiology & Pain Medicine [PHONE_1206] [EMAIL_1269]  
 VERSION NUMBER/ DATE : 
Ver. 2/May 12, 2022  Revision History  
 
Revision 
# Version Date  Summary of Changes  Consent 
Change?  
1 5/12/[ADDRESS_929960]. Tobias  and clarifying 
section 9.3.  Yes 
    
    
    
    
 
  
NATIONWIDE CHILDREN’S HOSPI[INVESTIGATOR_685985]  (Waiver of C onsent or Verbal Consent) 
 
PROTOCOL TITLE:  Parental perceptions on prescription opi[INVESTIGATOR_685986] 2 of 7
 HRP -580  v.04.17.19   
1.0  Study Summary   
 
Study Title  Parental perceptions on prescription opi[INVESTIGATOR_685988] s urvey  
Primary Objective  The primary objective of the study is parental perceptions on 
prescription opi[INVESTIGATOR_685989](s)  The secondary objective is to assess social and 
environmental factors in opio id perception among parents  
Study Population  Parents of children undergoing orthopedic surgery at NCH  
Sample Size  125 
Study Duration  3 years  
 
2.0  Methods  
2.1 Potential subjects will be identified by [CONTACT_685991]. Parents will be approached in the pre-op area on the day of surgery, the study will be explained to them, and a written information sheet will be provided. 
2.2 After receiving verbal consent, the parents will be given a research iPad and asked to complete the survey on REDCap (see attached survey). 
2.3 All continuous variables will be  summarized using mean +/ - 
standard deviation and categorical variables using counts and percentages. The chi -square test will be used to test whether parental 
perceptions on opi[INVESTIGATOR_685990], educational, or employment status.  
3.[ADDRESS_929961]-protected network.  
3.2 Data will be stored for 6 years after the study is completed . 
3.3 Data will not be stored for future use. 
4.0  Inclusion and Exclusion Criteria  
4.1 Inclusion: P arents of patients between 1 -18 years of age scheduled for 
orthopedic surgery at Nationwide Children’s Hospi[INVESTIGATOR_307]. 
4.2 Exclusion:  Parents with children less than 1 or greater than 18 years of age; 
scheduled for surgery other than orthopedic; non-English speaking parents. 
NATIONWIDE CHILDREN’S HOSPI[INVESTIGATOR_685985]  (Waiver of C onsent or Verbal Consent) 
 
PROTOCOL TITLE:  Parental perceptions on prescription opi[INVESTIGATOR_685986] 3 of 7
 HRP -580  v.04.17.19   
5.0 Vulnerable Populations  
5.1 This research involves children but does not involve greater than minimal 
risk under 21 CFR §50.51/45 CFR §46.404.  
5.[ADDRESS_929962] -protected network.  
 
6.0 Number of Subjects  (Records)  
6.1 125  
7.0 Recruitment Methods  
7.1 Subjects will be recruited from the surgery unit pre- op area.  They will be 
identified by [CONTACT_477974]. 
8.0 Withdrawal of Subjects  
8.1 N/A 
9.[ADDRESS_929963] information will not be given to any other investigators. Subjects and their information will be closely monitored and guarded by [CONTACT_464]; there will be limited access to patients and their information by [CONTACT_3665]; and subject information will only be shared and discussed between study staff specific to this study. 
10.2 Patie nt charts will only be accessed for screening purposes. No 
patient information will be recorded.   
11.0 Economic Burden to Subjects  
NATIONWIDE CHILDREN’S HOSPI[INVESTIGATOR_685985]  (Waiver of C onsent or Verbal Consent) 
 
PROTOCOL TITLE:  Parental perceptions on prescription opi[INVESTIGATOR_685986] 4 of 7
 HRP -580  v.04.17.19  11.1 There will be no costs to subjects and subjects will not receive any 
compensation. 
12.0 Consent Process  
12.1 We are requesting a waiver of documentation of informed consent. 
12.2
 The consent process will begin in the preoperative surgery unit on the day of surgery, by [CONTACT_976], Sub
-I
nvestigators, Study Coordinators, 
and/or trained research staff .  
12.[ADDRESS_929964] identifiers will be recorded for this research.  
☐  Name  
☐  Complete Address 
☐  Telephone or Fax Number  
☐  Social Security Number (do not check if only used for ClinCard) ☐  Dates (treatment dates, birth date, date of death) ☐  Email address , IP address or url 
☐  Medical Record Number or other account number 
☐  Health Plan Beneficiary Identification Number ☐  Full face photographic images and/or any comparable images (x- rays) 
☐  Account Numbers 
NATIONWIDE CHILDREN’S HOSPI[INVESTIGATOR_685985]  (Waiver of C onsent or Verbal Consent) 
 
PROTOCOL TITLE:  Parental perceptions on prescription opi[INVESTIGATOR_685986] 5 of 7
 HRP -580  v.04.17.19  ☐  Certificate/License Numbers  
☐  Vehicle Identifiers and Serial Numbers (e.g. VINs, License Plate Numbers)  
☐  Device Identifiers and Serial Numbers  
☐  Biometric identifiers, including finger and voice prints 
☐  Other number, characteristic or code that could be used to identify an 
individual 
☒  None (Complete De- identification Certification Form)  
 
2.0   Check the appropriate category and attach the required form*  on the Local 
Site Documents, #3. Other Documents , page of the application.  (Choose one.) 
☐  Patient Authorization will be obtained. (Include the appropriate HIPAA 
language (see Section 14 of consent template) in the consent form OR attach  
the HRP -900, HIPAA AUTHORIZATION form.) 
☒  Protocol meets the criteria for waiver of authorization. (Attach the HRP -901, 
WAIVER OF HIPAA AUTHORIZATION REQUEST  form.)  
☐  Protocol is using de- identified information. (Attach the HRP -902, DE -
IDENTIFICATION CERTIFICATION form.) (Checked "None" in 1.0 above)  
☐  Protocol involves research on decedents. (Attach the HRP -903, RESEARCH 
ON DECEDENTS REQUEST  form.)  
☐  Protocol is using a limited data set and data use agreement. (C ontact the 
Office of Technology Commercialization to initiate a Limited Data Use Agreement.  
 
*Find the HIPAA forms in the IRB Website Library, Templates.  
 
Attach the appropriate HIPAA form  on the “Local Site Documents, #3. Other 
Documents”, page of the application. 
 3.0    How long will identifying information on each participant be maintained?  
No identifying information will be collected.  
 
4.0 Describe any plans to code identifiable information collected about each 
participant.  N/A 
 
5.[ADDRESS_929965] the 
confidentiality of information collected for this research : 
☒ Research records will be stored in a locked cabinet in a secure location  
☒ Research records will be stored in a password -protected computer file 
☐ The list linking the assigned code number  to the individual subject will be 
maintained separately from the other research data  
☒ Only certified research personnel will be given access to identifiable 
subject information  
NATIONWIDE CHILDREN’S HOSPI[INVESTIGATOR_685985]  (Waiver of C onsent or Verbal Consent) 
 
PROTOCOL TITLE:  Parental perceptions on prescription opi[INVESTIGATOR_685986] [ADDRESS_929966] the privacy     interests of subjects, where "privacy interests" refer to the interest of individuals in being left alone, limiting access to them, and limiting access to their information. (This is not the same provision to maintain the confidentiality of data.) Subject information will not be given to any other investigators. Subjects and their information will be closely monitored and guarded by [CONTACT_464]; there will be limited access to patients and their information by [CONTACT_3665]; and subject information will only be shared and discussed between study staff specific to this study. 
 Confidential Health Information  1.[ADDRESS_929967] the nature of health information to be accessed and used as part of this research.  
 
☒  Demographics (age, gender, educational level)  
☐  Diagnosis 
☐  Laboratory reports  
☐  Radiology reports 
☐  Discharge summaries  
☒  Procedures/Treatments received  
☐  Dates related to course of treatment (admission, surgery, discharge) ☐  Billing information  
☐  Names of drugs and/or devices used as part of treatment 
☐  Location of treatment 
☐  Name [CONTACT_64546]  
☐  Surgical reports 
☐  Other informa tion related to course of treatment 
☐  None 
 
2.0 Please discuss why it is necessary to access and review the health information 
noted in your response above.  It is necessary to review the above health information to ensure that potential subjects  meet the study inclusion specifications. 
 
3.0 Is the health information to be accessed and reviewed the minimal necessary 
to achieve the goals of this research?  ☒ Yes    ☐ No  
 4.[ADDRESS_929968] information of a sensitive nature?   ☐ Yes  ☒ No  
 
NATIONWIDE CHILDREN’S HOSPI[INVESTIGATOR_685985]  (Waiver of C onsent or Verbal Consent) 
 
PROTOCOL TITLE:  Parental perceptions on prescription opi[INVESTIGATOR_685986] 7 of 7
 HRP -580  v.04.17.19  5.0 Do you plan to obtain a federally- issued Certificate of Confidentiality as a 
means of protecting the confidentiality of the information collected?   ☐ Yes   
☒ No  
 
 